Enuresis, a term that many medical professionals are familiar with but may not fully understand. Enuresis is commonly known as bedwetting and can have a significant impact on both the physical and emotional well-being of those affected by it. In this comprehensive overview, we will define enuresis, explore its various types, dive into potential causes, and provide insights for medical professionals to better diagnose and treat their patients. So let's get started!
Enuresis refers to the involuntary release of urine during sleep, beyond an age where a child is expected to have dry nights. It can be classified as either primary or secondary enuresis depending on whether the individual has ever been consistently dry at night before developing bedwetting.
Primary enuresis occurs when the individual has never achieved consistent nighttime bladder control (i.e., never had more than six months without wetting). It is more common among children and typically resolves with time. Secondary enuresis happens when an individual who previously had gained nighttime bladder control experiences a return in bedwetting after being dry for at least six months.
Nocturnal Enuresis Definition specifically refers to bedwetting that only occurs at night, whereas diurnal enuresis describes daytime urinary incontinence.
Enuresis, commonly known as bedwetting, is a condition that affects both children and adults. There are two main types of enuresis: primary and secondary. Primary enuresis occurs when the individual has never had urinary control during sleep consistently. Secondary enuresis happens when an individual who previously had bladder control while sleeping starts experiencing bedwetting again.
Another way of classifying enuresis is based on the timing of incidents - daytime or nighttime wetting. Nocturnal Enuresis is a type of bedtime wetting where individuals experience involuntary urine loss while asleep at night. Diurnal Enuresis occurs during waking hours in some people.
The different types of enuresis can have various causes ranging from genetic factors to psychological issues like stress and anxiety. Therefore, it's vital for medical professionals to understand the various categories so they can make accurate diagnoses and provide appropriate treatments for patients with this condition.
Enuresis, also known as bedwetting, can be caused by a variety of factors. One common cause is genetics. If one or both parents experienced enuresis during childhood, their child is more likely to develop the condition as well.
Another factor that can contribute to enuresis is bladder control issues. Children who struggle with holding in urine for extended periods of time may experience accidents at night when they are sleeping and not able to wake up to go to the bathroom.
Enuresis is a relatively common condition that affects both children and adults. It is defined as the involuntary discharge of urine during sleep or while awake and can have physical, psychological, or emotional causes.
There are two main types of enuresis: primary and secondary. Primary enuresis occurs when a person has never been dry for an extended period, whereas secondary enuresis happens after a prolonged period of urinary continence.
Understanding the underlying causes of enuresis can help healthcare professionals develop appropriate treatment plans for their patients. Treatment options range from behavioral interventions to medication therapies depending on the specific cause of the condition.
1.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
2.
New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.
3.
Research finds stark disparities in treatment and survival time for people with pancreatic cancer
4.
Tumor characteristics found to differ for melanomas in children, teens and young adults
5.
Relationship-building key to addressing oncologist shortages in rural care
1.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
2.
Colon cancer: Risk factors, warning signs and treatment options
3.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
4.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
3.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation